4.7 Article

Article Cell culture systems for isolation of SARS-CoV-2 clinical isolates and generation of recombinant virus

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation

Da-Yuan Chen et al.

Summary: The Omicron variant of SARS-CoV-2 is highly immune evasive but less virulent compared to other major viral variants. It has a large number of mutations in the spike protein, which is the main driver of these traits. The virus bearing Omicron S can efficiently escape vaccine-induced immunity, replicate in cells, and cause less severe disease, but its pathogenicity is determined by mutations both in and outside of the spike protein.

NATURE (2023)

Article Multidisciplinary Sciences

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele et al.

Summary: The study found that the Omicron variant has reduced neutralizing effectiveness in individuals vaccinated with Pfizer BNT162b2, but those who had previously been infected with SARS-CoV-2 showed better neutralization against Omicron.

NATURE (2022)

Article Multidisciplinary Sciences

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Rigel Suzuki et al.

Summary: The Omicron variant of SARS-CoV-2 has spread rapidly in several countries and has shown lower fusogenicity and attenuated pathogenicity compared to the Delta variant.

NATURE (2022)

Article Virology

Sequencing during Times of Change: Evaluating SARS-CoV-2 Clinical Samples during the Transition from the Delta to Omicron Wave

Shuchen Feng et al.

Summary: This study investigates the lineages and host-specific mutations in a vulnerable population of SARS-CoV-2-infected patients during the transition from Delta to Omicron wave. The findings suggest ongoing evolution of the virus and novel mutations in individual patients, which is important for informing public health strategies.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Article Infectious Diseases

Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile

Nathalie Wurtz et al.

Summary: The study tested 4 locally isolated strains of SARS-CoV-2 on 34 cell lines commonly used for isolating human pathogenic microorganisms, finding that 7 cell lines were able to support virus replication. Results indicate that there are differences in cytopathogenic effects and multiplication abilities in cells with different strains.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Bryan A. Johnson et al.

Summary: The genetic mutation in SARS-CoV-2 resulted in better fitness in some cells but lower replication capacity in human respiratory cell lines. Despite reducing disease symptoms, the Delta PRRA mutant provided protection against rechallenge with the wildtype SARS-CoV-2.

NATURE (2021)

Article Biochemistry & Molecular Biology

Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination

Alexandra Herrmann et al.

Summary: The development of a passage-free SARS-CoV-2 clone and generation of reporter and marker viruses using Red recombination have facilitated antiviral testing and tracking of viral replication at the single-cell level, providing a powerful platform for studying the biology of SARS-CoV-2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Virology

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

Helena Winstone et al.

Summary: The presence of a polybasic cleavage site in the spike protein of SARS-CoV-2 allows the virus to enter cells in a pH-independent manner, mitigating against IFITM-mediated restriction and promoting replication and transmission. Targeted depletion of IFITM2 expression alleviates potent inhibition of SARS-CoV-2 replication by type I IFNs. Therapeutic strategies targeting furin-mediated cleavage of the spike protein may reduce viral replication through the activity of type I IFNs.

JOURNAL OF VIROLOGY (2021)

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Article Multidisciplinary Sciences

MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2

Kentaro Uemura et al.

Summary: The study aimed to develop a virus-susceptible human cell line for SARS-CoV-2 research, with findings showing that MRC5/ACE2 cells will be crucial in the development of specific anti-viral therapeutics and in assisting vaccine development to combat SARS-CoV-2 infections.

SCIENTIFIC REPORTS (2021)

Article Virology

Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike

John James Baczenas et al.

Summary: The study showed that propagating B.1.351 SARS-CoV-2 stock on Calu-3 cells can eliminate mutations accumulated in the furin cleavage site, while maintaining pathogenicity in animal models. However, caution should be taken to evaluate virus stocks for newly arising mutations during propagation.

VIRUSES-BASEL (2021)

Article Biochemistry & Molecular Biology

Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

Nicole L. Washington et al.

Summary: The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom, has been spreading in the United States with multiple introductions as early as late November 2020. The variant shows a logistic growth rate with roughly weekly doubling and increased transmission, requiring immediate action to minimize COVID-19 morbidity and mortality.
Article Infectious Diseases

Novel SARS-CoV-2 variants: the pandemics within the pandemic

Erik Boehm et al.

Summary: Many new variants of SARS-CoV-2 have been identified as variants of concern/interest due to increased transmissibility, severity, immune escape, and reduced vaccine efficacy. These variants often share similar mutations, such as N501Y and E484K, which lead to partial immune escape, decreased vaccine efficacy, and potentially increased severity.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Cell Biology

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction

Shiho Torii et al.

Summary: A PCR-based, bacterium-free method has been developed to generate SARS-CoV-2 infectious clones, allowing for a better understanding of the virus through the construction of reporter and mutant viruses.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 variants reveal features critical for replication in primary human cells

Marie O. Pohl et al.

Summary: This study characterized different SARS-CoV-2 isolates from major European clades during the early phase of the pandemic in 2020 and identified sequence features associated with distinct phenotypes, such as variations affecting replication in specific cell types. It highlights the importance of carefully monitoring newly emerging variants or potential variants of concern in SARS-CoV-2 stocks.

PLOS BIOLOGY (2021)

Article Biology

Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation

Mart M. Lamers et al.

Summary: Virus propagation in different cell conditions may lead to adaptive mutations, but propagating SARS-CoV-2 in human airway cells expressing serine proteases can prevent these adaptations.

ELIFE (2021)

Editorial Material Biology

COVID-19: Avoiding culture shock with the SARS-CoV-2 spike protein

Benjamin G. Hale

ELIFE (2021)

Article Microbiology

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Thomas P. Peacock et al.

Summary: Efficient transmission of SARS-CoV-2 among infected ferrets is dependent on a functional furin cleavage site in the spike protein. The virus has a selective advantage in lung cells and primary human airway epithelial cells due to a polybasic insertion, but replication may be impaired in certain cell lines.

NATURE MICROBIOLOGY (2021)

Article Virology

SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway

Da-Yuan Chen et al.

Summary: SARS-CoV-2 can infect multiple organs in the human body and evade host antiviral immunity by suppressing interferon signaling. Targeting viral mediators of immune evasion may help block virus replication.

JOURNAL OF VIROLOGY (2021)

Article Multidisciplinary Sciences

Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies

Claudia Pommerenke et al.

Summary: This study aims to identify suitable cancer cell lines for drug screening and virus research by screening ACE2 and TMPRSS2 genes in cancer cell lines; however, limited correlation between receptor expression and cell permissiveness was found in experimental results; in terms of viral infection, cell permissiveness is not only influenced by the presence of entry receptors but also by factors such as cellular resources, intrinsic immunity, and apoptosis.

PLOS ONE (2021)

Article Multidisciplinary Sciences

A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

Alberto A. Amarilla et al.

Summary: The study shows that a simplified reverse genetics method can efficiently assemble infectious full-length cDNA, enabling easier in vitro and in vivo characterization of viruses like SARS-CoV-2.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell

Maritza Puray-Chavez et al.

Summary: This study identifies human H522 lung adenocarcinoma cells as permissive to SARS-CoV-2 infection and reveals the importance of the E484D S variant for infection. Vaccinated individuals' sera block the alternative entry mechanism, whereas convalescent sera are less effective.

CELL REPORTS (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Multidisciplinary Sciences

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

Tran Thi Nhu Thao et al.

NATURE (2020)

Article Biotechnology & Applied Microbiology

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Natacha S. Ogando et al.

JOURNAL OF GENERAL VIROLOGY (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Yixuan J. Hou et al.

SCIENCE (2020)

Article Immunology

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction

Siu-Ying Lau et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Medicine, General & Internal

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Ali Moh Zaki et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

C Drosten et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)